Calaspargase pegol-mnkl
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Calaspargase pegol-mnkl, covering 2025-11-28 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 1]